News
The company has brought down the price range. It now starts at Rs 16.75 lakh (ex-showroom), making it more accessible to the ...
Corvus' soquelitinib shows promise in oncology & autoimmune fields, with Phase 3 PTCL data as a key catalyst. Click here to ...
(100%) in the 180mg cohort achieved a clinical response Tryptase levels below the lower limit of quantification observed in ...
The nicest car you’ve never heard of - CAR REVIEW: With the looks of a Cayenne and Tesla tech at a bargain price, Sean ...
During a Community Case Forum event, Adil Daud, MD, discussed immunotherapy options for cutaneous squamous cell carcinoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results